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Introduction
The sequence of the human genome is at hand. Most
scientists who use the sequence will rely on annotations
that provide information about the number and loca-
tion of genes and about their inferred protein products.
Traditionally, genes have been annotated by scientists
with a particular interest in them. However, annota-
tion of the complete human genome sequence will have
to be at least partially automated. Gene annotation in-
corporates cDNA data (including expressed sequence
tags [ESTs]), sequence similarity, and computational pre-
dictions based on the recognition of probable splice
sites and coding regions (Stormo 2000; also see David
Haussler’s Web site, Computational Genefinding). The
state of the art was recently surveyed by the Genome
Annotation Assessment Project-GASP1 and must be re-
garded as imperfect (Bork 2000; Reese et al. 2000).
This review enumerates aspects of pre-mRNA splicing
that limit our ability to predict gene structure from ge-
nomic sequence, drawing on the recently annotated
complete genome of Drosophila melanogaster (Adams
et al. 2000) as an example. In particular, the following
four facts will be discussed. First, splice sites do not
always conform to consensus. Second, noncoding exons
are common. Third, internal exons can be arbitrarily
small, and small internal exons confound not only gene
finding but also the alignment of cDNA and genomic
sequences. Fourth, splice sites are not recognized in iso-
lation, and nucleotides that are far from splice sites can
affect splicing. This list and the accompanying analysis
should make molecular geneticists aware of the ways
in which gene annotations can be wrong and should
encourage recourse to the primary data. In addition, the
same considerations indicate that inherited disease can
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be caused by mutations remote from splice sites that
nevertheless affect splicing.
Discussion
Splice Sites Do Not Always Conform to Consensus
It is well established that nearly all splice sites conform
to consensus sequences (Mount 1982; Senapathy et al.
1990; Zhang 1998). These consensus sequences include
nearly invariant dinucleotides at each end of the in-
tron—GT at the 5′ end of the intron and AG at the 3′
end of the intron. Most gene-finding software and most
human annotators will find only introns that begin with
a GT and end with an AG. However, nonconsensus
splice sites have been described, and I will discuss three
classes, in decreasing order of frequency.
The most common class of nonconsensus splice sites
consists of 5′ splice sites with a GC dinucleotide. Sen-
apathy et al. (1990) listed 17 examples among 3,724 5′
splice sites, suggesting a frequency of ∼0.5%. Jackson
(1991) listed a total of 26 GC sites, whereas Wu and
Krainer (1999) cited an additional 18 examples. GC 5′
splice sites are consistent with the experimental obser-
vation that, of the six possible point mutations within
the GT dinucleotide, mutation of T to C in position 2
has the smallest effect on in vitro splicing (Aebi et al.
1986). At other positions within the consensus, GC sites
conform extremely well to the standard consensus; for
example, 42 of the 44 sites cited above have a consensus
G residue at both position 1 and position 5. It is
reasonable to assume that GC sites are recognized by
the standard (U2-dependent) spliceosome.
The second class of exception to splice-site consensus
is U12 introns, a minor class of rare introns with splice-
site sequences that are very different from the standard
consensus but that are very similar to each other. The
existence of this class was first pointed out by Jackson
(1991) and was considered in more detail by Hall and
Padgett (1994). It was subsequently discovered that U12
introns are removed by a minor spliceosome containing
the rare U11, U12, U4atac, and U6atac snRNPs, in place
of U1, U2, U4, and U6 (Tarn and Steitz 1997; Burge et
al. 1998). Some U12 introns have AT and AC in place
of GT and AG and are known as “AT-AC” introns.
However, terminal intron dinucleotide sequences do not
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distinguish between U2- and U12-dependent introns
(Dietrich et al. 1997). Rather, U12 introns can be iden-
tified by highly conserved sequences at the 5′ splice site
(RTATCCTY; Rp A or G, and Yp C or T) and branch
site (TCCTRAY). U12 introns are found in many eu-
karyotes, including Drosophila melanogaster (Adams et
al. 2000) and Arabidopsis thaliana (Shukla and Padgett
1999) but not Caenorhabditis elegans.
Finally, there are a small number of nonconsensus sites
that fit into neither of the two categories mentioned
above. Many reports of such variant splice sites can be
traced to errors in annotation or interpretation, poly-
morphic differences between the sources of cDNA and
genomic sequence, inclusion of pseudogene sequences,
or failure to account for somatic mutation (author’s un-
published data; for examples, see Jackson 1991). How-
ever, there are many examples of sites that match the
consensus very poorly, and experimental work has es-
tablished that 5′ splice sites do not absolutely require
GT—and that 3′ splice sites do not absolutely require
AG—in order to be recognized in vivo (Aebi et al. 1986;
Roller et al. 2000, and references therein). In yeast, an
intron that is within the HAC1 mRNA and that has no
similarity to the standard nuclear pre-mRNA intron con-
sensus sequence is spliced by a specific, regulated, en-
donuclease and tRNA ligase (Sidrauski et al. 1996). This
intron provides a precedent for introns in protein-coding
genes with completely novel splice sites.
Noncoding Exons Are Common
There is considerable confusion between exons and
coding regions. The term “exon” was coined by Gilbert
(1978) to refer to what is left when introns are removed
by splicing, and RNAs that are entirely noncoding (such
as tRNAs) are sometimes spliced. However, the term
exon is often misused to refer to a stretch of coding
information. In reality, however, noncoding exons are
quite common, occurring in 135% of human genes
(Zhang 1998). Gene-finding software generally detects
sequence features characteristic of coding regions rather
than of exons and does not even attempt to identify
noncoding exons, or noncoding portions of exons. This
is because the statistical biases introduced by protein-
coding are in fact a very powerful tool for the identifi-
cation of coding DNA, and no similar tool has been
developed for the identification of noncoding exons.
A similar problem can arise in genes without non-
coding exons. If the first intron occurs near the initiator
AUG, then the coding information in the first exon can
be very short and difficult to identify by measures of
coding tendency. Furthermore, the first intron tends to
be longer than average (Maroni 1996), and such an ar-
rangement can separate promoter function (perhaps in-
cluding downstream transcriptional enhancer elements
lying in the first intron) from the bulk of the coding
information downstream. In these cases, investigators
have no way of knowing how much information is miss-
ing—or where the 5′ end of the gene is likely to re-
side—without experimental data such as a cDNA se-
quence or a 5′ EST.
Internal Exons Can Be Arbitrarily Small
A less frequent but perhaps more serious problem for
gene-discovery methods is posed by small internal exons.
Vertebrate internal exons have an average size of ∼130
nucleotides (Hawkins 1988; Zhang 1998), and roughly
65% of internal human exons are 68–208 nucleotides
in length (Maroni 1996). This size distribution reflects
a functional constraint. Optimal splicing efficiency re-
quires exons with sizes of ∼50–300 nucleotides (Rob-
berson et al. 1990; Dominski and Kole 1991; see re-
view by Berget 1995). However, a considerable number,
110%, of exons are !60 nucleotides in length, and it is
these exons that can be difficult to identify by measures
of coding tendency.
Just how small can internal exons be? There appears
to be no lower limit, and many cases of exons !10 nu-
cleotides have been described (for examples, see Stamm
et al. 1994; also see the author’s Web site, Gene An-
notation and Splice Site Selection). An illustrative case
is the invected gene of D. melanogaster (also listed in
GadFly as CG17835). This gene encodes a homeodo-
main protein that is similar to engrailed, and these two
genes are adjacent. One of four invected exons is only
6 nucleotides long and is flanked by introns of 27,659
and 1,134 nucleotides. Significantly, this exon is not rec-
ognized by cDNA alignment software such as SIM4 (Flo-
rea et al. 1998), and the gene is incorrectly annotated
(GenBank accession number AE003825.1). As a result,
the protein sequence predicted by annotation of the
genome (Adams et al. 2000; GenBank accession num-
ber AAF58640) differs from that predicted from the
cDNA (Coleman et al. 1987; GenBank accession number
CAA28885), because of a frameshift affecting the entire
carboxyl-terminal coding exon, a highly conserved re-
gion of the protein. This is despite the fact that the mi-
croexon sequence, GTCGAA, is flanked by intron se-
quences that perfectly match the splice-site consensus.
Use of this microexon provides perfect agreement be-
tween the cDNA and genomic sequences when consen-
sus splice sites are used, whereas the annotation predicts
an RNA with several discrepancies relative to the cDNA.
The frameshift is due to the predicted use of a 5′ splice
site 10 nucleotides downstream of the true 5′ splice site,
which was apparently selected to account for the mi-
croexon. It seems clear that the protein sequence pre-
dicted by the cDNA is correct. Why was it not incor-
porated into the annotation? The alignment problem
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Figure 1 Small internal exons and resplicing. This schematic
figure indicates the pathway of resplicing demonstrated for the Dro-
sophila Ubx locus (Hatton et al. 1998). The thicker vertical line in-
dicates a resplicing site, which does not contribute any nucleotides to
the final mRNA product. The same pathway could be followed in the
case of a microexon, in which case an arbitrarily small number of
nucleotides would remain in the mRNA product. “Up. Exon” and
“Down. Exon” denote the exons upstream and downstream of the
resplicing site, respectively. In the case of Ubx, the sequence imme-
diately downstream of the resplicing site is an alternatively spliced
exon (here designated “Alt. Exon), but resplicing sites are not always
accompanied by such alternatively spliced exons (J. Burnette and A.
J. Lopez, personal communication).
arises because a pattern-matching algorithm that locates
exons by similarity between the cDNA and the genomic
sequence cannot find exons of this size unless its strin-
gency is reduced to an unacceptable level (Florea et al.
1998).
The notion that exons can be arbitrarily small is sup-
ported by the observation of exons with length 0. Of
course, such sites are not exons at all but, rather, are
resplicing sites (see fig. 1). This phenomenon has been
demonstrated in the case of the Drosophila Ultrabi-
thorax locus (Hatton et al. 1998), which has a region
of 60 kb containing two alternatively spliced exons, and
may be a general feature of long introns (J. Burnette and
A. J. Lopez, personal communication). The existence of
resplicing sites not only illustrates the lack of a lower
limit to exon size (which has implications for gene an-
notation) but also has implications for the analysis of
hereditary mutations. A mutation at one of these sites
could potentially create a frozen intermediate such as
that diagrammed in figure 1. This partially spliced RNA
would probably be unstable, because of nonsense-me-
diated decay (Culbertson 1999), and the apparent result
would be no RNA (rather than aberrantly spliced RNA).
Such mutations would be very hard to identify.
Nucleotides Far from Splice Sites Can Affect Splicing
No method of evaluating potential splice sites that is
based on sequence alone can be 100% reliable. One can
be sure of this because many sequences that are not splice
sites are capable of acting as splice sites, and vice versa.
Perhaps the clearest demonstration of this is provided
by the activation of cryptic splice sites. These are splice
sites that are used, sometimes with 100% efficiency,
when a natural splice site has been mutationally inac-
tivated. The activation of cryptic sites occurs in ap-
proximately one-third of splicing mutations (Nakai and
Sakamoto 1994). The phenomenon shows that the cryp-
tic sites are perfectly capable of being recognized by the
splicing machinery. Clearly, the sequence of such cryptic
sites is compatible with splicing, and context is impor-
tant for splice-site choice.
Two contextual elements that contribute to splice-
site selection are the location of splice sites relative to
each other and splicing-enhancer sequences. The exon-
size preferences described above are widely understood
in terms of an exon-definition model that includes the
interaction of splicing factors bound at either end of an
exon (Berget 1995). The requirement for productive in-
teractions among splicing factors, including U1 snRNPs
at the 5′ splice site and U2 snRNP auxiliary factor
(U2AF) at the 3′ splice site, are thought to give rise to
preferred exon lengths because of steric constraints and
geometry favoring interactions. In the case of small in-
trons, a similar model of intron bridging has been pro-
posed (Guo and Mount 1995; McCullough and Berget
1997). In combination, these models suggest that, in
order to be recognized, a splice site must have a partner
an appropriate distance away, so that either exon defi-
nition or intron definition is facilitated by the spacing.
One experimental distinction between exon definition
and intron definition is the result of mutations that in-
activate the splice site. Failure to undergo exon definition
results in exon skipping, whereas failure to undergo in-
tron definition results in intron retention.
Not only is the use of one splice site dependent on the
presence of its partner across the exon, but weakness in
one partner can be compensated by strength in the other,
as seen with second-site revertants of splice-site muta-
tions that cause exon skipping. In an analysis of splicing
mutations at the dihydrofolate reductase locus, Caroth-
ers et al. (1993) found that a mutation at the 5′ splice
site of exon 5 (G to C in the third position of the intron)
could be partially reversed by mutations that increased
the strength of the 3′ splice site upstream of the same
exon (AAAGF to TTAGF, ACAGF, or ATAGF). Al-
though reversion was not complete, these data provide
a strong argument that whether a sequence functions as
a splice site depends not only on its intrinsic strength
but also on its context. Similarly, there are mutations
that create splice sites within introns, activating cryptic
exons by recruitment of appropriately placed partners
(e.g., see Bagnall et al. 1999).
Splicing enhancers are sequences that stimulate
splicing at nearby sites. A family of non-snRNP splic-
ing factors known as “SR proteins” appear to be im-
portant for the recognition of splicing enhancers in
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exons (Blencowe 2000). A splicing difference between
SMN1 and SMN2, which explains their differential
effects on spinal muscular atrophy, has been attrib-
uted to a translationally silent substitution within the
coding sequence that affects splicing (Lorson et al.
1999). Similarly, H.-X. Liu, L. Cartegni, M. Q.
Zhang, and A. R. Krainer (personal communication)
have shown that a nonsense mutation causing the
skipping of BRCA1 exon 18 affects splicing in vitro
and that a missense mutation at the same position can
also cause exon skipping. There are also splicing-en-
hancer sequences in introns—and examples of mu-
tations that affect them (Cogan et al. 1997). Although
general mechanisms for their function have yet to be
defined, there is some evidence that at least some splic-
ing enhancers in introns may act by facilitating exon
definition in the case of small exons (Carlo et al.
2000).
Outlook
This review has presented aspects of pre-mRNA splicing
that pose special problems for gene annotation. How-
ever, even though the best gene finders predict genes
exactly right less than half the time, 95% of total coding
nucleotides are predicted accurately, and !5% of genes
are completely missed (Reese et al. 2000; Genome An-
notation Assessment Project-GASP1). When cDNA and
homology data are available, annotations will tend to
be even better. Thus, one would be wrong to conclude
from this review that the gene annotations attending the
human genome sequence will not provide an extremely
valuable resource. Nevertheless, molecular geneticists
will want to have an understanding of the kinds of errors
that are likely to occur—and to carefully review the
available evidence for genes that matter to them. An-
notators are likewise obligated to make the source of
each specific aspect of their annotation an integral part
of the annotation; for example, if part of the annotation
is supported by a EST whereas the rest of it is based on
the prediction of a gene finder, then the limits of the
cDNA should be indicated, and the accession number
of the EST should be part of the annotation.
A related but distinct point is that these same factors
are also relevant when candidate mutations are evalu-
ated during the analysis of hereditary disease. Mutations
that lie within splicing enhancers, at resplicing sites, or
at cryptic splice sites can affect splicing even when they
lie some distance from the splice sites actually used in
the generation of the affected mRNA. The problem is
further compounded by alternative splicing and the in-
terplay between splicing and polyadenylation, topics
that are beyond the scope of the present review.
In summary, gene annotations will be a valuable re-
source. However, they will not substitute for expertise
in molecular genetics.
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